St. Mary's Medical Center is a hospital in San Francisco, California, US. It is currently operated by Dignity Health.

There are 403 beds in St Mary's Medical Center.

During the past decade, St Mary's Medical Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St Mary's Medical Center" #1 sponsor was "Effector Therapeutics" with 2 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored, "Active Implants" with 1 trials sponsored and "Celgene" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St Mary's Medical Center" #1 collaborator was "Medpace, Inc." with 1 trials as a collaborator and "University of Arizona" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "St Mary's Medical Center" are "HIV Infections" (2 trials), "Malignant Melanoma" (2 trials), "Basal Cell Carcinoma" (1 trials), "Cardiac Arrhythmia" (1 trials) and "Cutaneous Squamous Cell Carcinoma" (1 trials). Many other conditions were trialed in "St Mary's Medical Center" in a lesser frequency.

Most popular intervention types in "St Mary's Medical Center" are "Drug" (5 trials), "Device" (3 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "ABI-007" (1 trials), "Coxsackievirus A21 (CVA21)" (1 trials), "Dacarbazine" (1 trials), "Multilevel Lumbar Fusion surgery" (1 trials) and "NUsurface® Meniscus Implant" (1 trials). Other intervention names were less common.

The vast majority of trials in "St Mary's Medical Center" are 11 trials for "All" genders.

Currently, there are NaN active trials in "St Mary's Medical Center". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in St Mary's Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St Mary's Medical Center, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

St Mary's Medical Center has several departments that took part in Clinical trials: "Northern California Melanoma Center, St. Mary's Medical Center" - 2 trials